These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


74 related items for PubMed ID: 6244009

  • 21. Brain regional gamma-aminobutyric acid (GABA) and locomotor activity: effect of long-term aldrin exposure.
    Jamaluddin S, Poddar MK.
    Pol J Pharmacol; 2003; 55(3):371-82. PubMed ID: 14506316
    [Abstract] [Full Text] [Related]

  • 22. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T, Carlson B, Correa M, Keene A, Morales M, Salamone JD.
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [Abstract] [Full Text] [Related]

  • 23. Changes in G-protein activity mediated through the stimulation of dopamine and GABA(B) receptors in the mesolimbic dopaminergic system of morphine-sensitized mice.
    Narita M, Shibasaki M, Mizuo K, Suzuki T.
    Addict Biol; 2003 Sep; 8(3):319-25. PubMed ID: 13129834
    [Abstract] [Full Text] [Related]

  • 24. Preliminary pharmacological investigation on 38 aminophosphonic acids and their derivatives.
    Kleinrok Z, Kolasa K, Chodkowska A, Mastalerz P, Kafarski P.
    Pol J Pharmacol Pharm; 1985 Sep; 37(5):575-84. PubMed ID: 3008130
    [Abstract] [Full Text] [Related]

  • 25. [Changes in the behavioral and biochemical effects of cerulein, an analog of cholecystokinin octapeptide, after prolonged administration of haloperidol].
    Vasar EE, Allikmets LKh, Soosaar AKh, Lang AE.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1987 Sep; 37(4):696-702. PubMed ID: 3673260
    [Abstract] [Full Text] [Related]

  • 26. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML, Trabucchi M.
    Prog Clin Biol Res; 1980 Sep; 39():181-93. PubMed ID: 6105670
    [No Abstract] [Full Text] [Related]

  • 27. The effect of muscimol on prolactin secretion in male rats.
    Meltzer HY, Simonovic M, Fang VS.
    Commun Psychopharmacol; 1978 Sep; 2(3):231-6. PubMed ID: 212248
    [No Abstract] [Full Text] [Related]

  • 28. The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.
    Dunstan R, Jackson DM.
    J Neural Transm; 1977 Sep; 40(3):181-9. PubMed ID: 874470
    [Abstract] [Full Text] [Related]

  • 29. [Ultrastructure of Mauthner neurons of fish following exposure to apamin].
    Moshkov DA, Tiras NR, Miroshnikov AI.
    Dokl Akad Nauk SSSR; 1979 Sep; 245(4):1014-6. PubMed ID: 219999
    [No Abstract] [Full Text] [Related]

  • 30. Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine).
    Loew DM, Vigouret JM, Jaton A.
    Adv Biochem Psychopharmacol; 1980 Sep; 23():63-74. PubMed ID: 6104915
    [No Abstract] [Full Text] [Related]

  • 31. A behavior analysis of the offspring of "haloperidol-sensitive" and "haloperidol-resistant" gerbils.
    Upchurch M, Schallert T.
    Behav Neural Biol; 1983 Nov; 39(2):221-8. PubMed ID: 6686931
    [Abstract] [Full Text] [Related]

  • 32. Attenuation of the behavioral response to quisqualic acid and glutamic acid diethyl ester by chronic haloperidol administration.
    Freed WJ, Cannon-Spoor HE, Rodgers CR.
    Life Sci; 1989 Nov; 44(18):1303-8. PubMed ID: 2654529
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological interactions between -hydroxybutyric acid and agents which modify cerebral -aminobutyric acid (GABA) metabolism.
    Benton D, Rick JT, Taberner PV.
    Br J Pharmacol; 1973 Mar; 47(3):648P-649P. PubMed ID: 4730861
    [No Abstract] [Full Text] [Related]

  • 34. Effects of subacute exposure to 1,2-dichloroethane on mouse behavior and the related mechanisms.
    Wang G, Qi Y, Gao L, Li G, Lv X, Jin YP.
    Hum Exp Toxicol; 2013 Sep; 32(9):983-91. PubMed ID: 23263856
    [Abstract] [Full Text] [Related]

  • 35. Chronic administration of haloperidol during development: behavioral and psychopharmacological effects.
    Spear LP, Shalaby IA, Brick J.
    Psychopharmacology (Berl); 1980 Sep; 70(1):47-58. PubMed ID: 6775334
    [Abstract] [Full Text] [Related]

  • 36. Possible receptor effects of chronic lithium administration.
    Bunney WE, Garland BL.
    Neuropharmacology; 1983 Mar; 22(3 Spec No):367-72. PubMed ID: 6304554
    [Abstract] [Full Text] [Related]

  • 37. Effects of maturation and aging on behavioral responses to haloperidol in the rat.
    Campbell A, Baldessarini RJ.
    Psychopharmacology (Berl); 1981 Mar; 73(3):219-22. PubMed ID: 6787640
    [Abstract] [Full Text] [Related]

  • 38. Effects of abrupt and gradual withdrawal from long-term haloperidol treatment on open field behavior of rats.
    Bernardi MM, Neto JP.
    Psychopharmacology (Berl); 1979 Nov; 65(3):247-50. PubMed ID: 117495
    [Abstract] [Full Text] [Related]

  • 39. [Interaction of lead compound and haloperidol in evaluation of mouse behavior].
    Borzecki Z, Korszeń A, Wójcik A, Borzecka H.
    Ann Univ Mariae Curie Sklodowska Med; 1988 Nov; 43():17-24. PubMed ID: 2856667
    [No Abstract] [Full Text] [Related]

  • 40. Behavioural interactions between imidazoleacetic acid and gamma-hydroxybutyric acid in rats and mice.
    Benton D, Kyriacou CP, Rick JT, Taberner PV.
    Eur J Pharmacol; 1974 Aug; 27(3):288-93. PubMed ID: 4425346
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.